Obesity is associated with lower risk of death in dementia

New investigational drug combining eloralintide and tirzepatide (EloraTZP) led to weight loss of up to 23.3% in people living with obesity and type 2 diabetes

Building effective multimodal care for obesity and comorbidities in the GLP-1 therapy era

The More Ultra-Processed Food People Ate, the Higher Their Risk of Disease and Death